You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CYSTEAMINE HYDROCHLORIDE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for cysteamine hydrochloride and what is the scope of freedom to operate?

Cysteamine hydrochloride is the generic ingredient in two branded drugs marketed by Recordati Rare and Leadiant Biosci Inc, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

Two suppliers are listed for this compound.

Summary for CYSTEAMINE HYDROCHLORIDE
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Finished Product Suppliers / Packagers: 2
Raw Ingredient (Bulk) Api Vendors: 119
Clinical Trials: 29
Patent Applications: 1,424
What excipients (inactive ingredients) are in CYSTEAMINE HYDROCHLORIDE?CYSTEAMINE HYDROCHLORIDE excipients list
DailyMed Link:CYSTEAMINE HYDROCHLORIDE at DailyMed
Recent Clinical Trials for CYSTEAMINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Nacuity Pharmaceuticals, Inc.Phase 1/Phase 2
Thiogenesis Therapeutics, Inc.Phase 2
ClĂ­nica De La Costa Ltda.Phase 2/Phase 3

See all CYSTEAMINE HYDROCHLORIDE clinical trials

Pharmacology for CYSTEAMINE HYDROCHLORIDE

US Patents and Regulatory Information for CYSTEAMINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Leadiant Biosci Inc CYSTARAN cysteamine hydrochloride SOLUTION/DROPS;OPHTHALMIC 200740-001 Oct 2, 2012 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Recordati Rare CYSTADROPS cysteamine hydrochloride SOLUTION/DROPS;OPHTHALMIC 211302-001 Aug 19, 2020 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.